Kevin K. Mccully
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$1.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 4, 2022 | NIH | STTR Phase I Oxygen-Guided Therapy for Optimal Rehabilitation for Peripheral Artery Disease | $7K | INFRARED RX, INC. |
| Sep 22, 2021 | NIH | STTR Phase I Oxygen-Guided Therapy for Optimal Rehabilitation for Peripheral Artery Disease | $247K | INFRARED RX, INC. |
| Aug 12, 2020 | NIH | STTR Phase II Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring | $671K | INFRARED RX, INC. |
| Sep 21, 2019 | NIH | STTR Phase II Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring | $677K | INFRARED RX, INC. |
| Sep 18, 2017 | NIH | STTR Phase I Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring | $183K | INFRARED RX, INC. |
Peer ranks
Federal funding#1,339
Awards as PI#470
Patents#505
Companies
- INFRARED RX, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.